MBX logo

MBXMBX Biosciences Inc.

$30.85
$1.12
(3.75%)
Today
Closed $30.99
$0.14
(0.45%)
After Hours
Updated: 05:48 PM EDT
EarningsAug 6
Mkt Cap$1.42B
Vol971,371.00
42

Bearish Sentiment

How do you feel about MBX?

News
all
press releases
This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here
MBX Biosciences has rallied more than 230% over the past year, but there's room for still more upside from current levels, according to UBS...
CNBC: Top News
News Placeholder
More News
News Placeholder
MBX Biosciences (NASDAQ:MBX) Trading Down 6.3% - Should You Sell?
MBX Biosciences (NASDAQ:MBX) Trading Down 6.3% - Time to Sell...
MarketBeat
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Given Consensus Rating of "Moderate Buy" by Analysts
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, MarketBeat Ratings...
MarketBeat
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Short Interest Up 20.4% in March
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling...
MarketBeat
News Placeholder
MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered MBX Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat
News Placeholder
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - What's Next?
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Time to Buy...
MarketBeat
News Placeholder
Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings
MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) - Analysts at Lifesci Capital issued their Q1 2026 earnings estimates for MBX Biosciences in a report released on Tuesday, March 31st. Lifesci Capital analyst P. Dolezal anticipates that the company will post earnings of ($0.66) per share for the quar...
MarketBeat
News Placeholder
MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital
Lifesci Capital raised MBX Biosciences to a "strong-buy" rating in a report on Tuesday...
MarketBeat
News Placeholder
MBX Biosciences (NASDAQ:MBX) Shares Up 8.5% - What's Next?
MBX Biosciences (NASDAQ:MBX) Stock Price Up 8.5% - What's Next...
MarketBeat
News Placeholder
MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest
MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 2,983,725 shares, a growth of 24.6% from the February 26th total of 2,395,339 shares. Based on an average...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.